Search Results - "Spiro, Timothy P"

Refine Results
  1. 1

    Pulmonary toxicities of biologics: a review by Peerzada, Maajid Mumtaz, Spiro, Timothy P, Daw, Hamed A

    Published in Anti-cancer drugs (01-02-2010)
    “…With the advancement of research in cancer treatment more and more drugs are being introduced for the treatment of cancer. In this review study, we have tried…”
    Get full text
    Journal Article
  2. 2

    Pulmonary toxicities of tyrosine kinase inhibitors by Peerzada, Maajid Mumtaz, Spiro, Timothy P, Daw, Hamed A

    Published in Clinical advances in hematology & oncology (01-11-2011)
    “…The incidence of pulmonary toxicities with the use of tyrosine kinase inhibitors (TKIs) is not very high; however, various case reports and studies continue to…”
    Get full text
    Journal Article
  3. 3

    Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential by Nihal, Minakshi, Mikkola, Debra, Horvath, Nancy, Gilliam, Anita C, Stevens, Seth R, Spiro, Timothy P, Cooper, Kevin D, Wood, Gary S

    Published in Human pathology (01-06-2003)
    “…Cutaneous lymphoid hyperplasia (CLH) has been proposed to be the benign end of a continuum of lymphoproliferative disorders with cutaneous lymphoma at its…”
    Get full text
    Journal Article
  4. 4

    Hepatitis B reactivation in cancer patients: role of prechemotherapy screening and antiviral prophylaxis by Kawsar, Hameem I, Shahnewaz, Jamila, Gopalakrishna, K V, Spiro, Timothy P, Daw, Hamed A

    Published in Clinical advances in hematology & oncology (01-06-2012)
    “…Hepatitis B virus (HBV) infection is a potentially life-threatening condition that can be effectively prevented by vaccination. In the United States, more than…”
    Get full text
    Journal Article
  5. 5

    Pharmacokinetics of O6-Benzylguanine (NSC637037) and Its Metabolite, 8-Oxo-O6-Benzylguanine by Tserng, Kou-Yi, Ingalls, Stephen T., Boczko, Erik M., Spiro, Timothy P., Li, Xiaolin, Majka, Susan, Gerson, Stanton L., Willson, James K. V., Hoppel, Charles L.

    Published in Journal of clinical pharmacology (01-08-2003)
    “…O6‐Benzylguanine and its metabolite, 8‐oxo‐O6‐benzylguanine, are equally potent inhibitors of the DNA repair enzyme, O6‐alkylguanine‐DNA alkyltransferase…”
    Get full text
    Journal Article
  6. 6

    The utility of 18-F-fluorodeoxyglucose positron emission tomography in evaluation of bone marrow involvement by non-Hodgkin lymphoma by Muslimani, Alaa A, Farag, Hany L, Francis, Smitha, Spiro, Timothy P, Chaudhry, Asif A, Chan, Vincent C, Taylor, Harris C, Daw, Hamed A

    Published in American journal of clinical oncology (01-10-2008)
    “…In non-Hodgkin lymphomas (NHLs), the bone marrow (BM) involvement is a sign of extensive disease and the iliac crest BM biopsy (BMB) is the established method…”
    Get full text
    Journal Article
  7. 7

    Aromatase Inhibitor–Related Musculoskeletal Symptoms: Is Preventing Osteoporosis the Key to Eliminating These Symptoms? by Muslimani, Alaa A, Spiro, Timothy P, Chaudhry, Asif A, Taylor, Harris C, Do, Ishmael Jaiyesimi, Daw, Hamed A

    Published in Clinical breast cancer (01-02-2009)
    “…Abstract Background Aromatase inhibitors (AIs) are an effective treatment for postmenopausal women with hormone receptor–positive breast cancer. However,…”
    Get full text
    Journal Article
  8. 8

    Sequential Tumor Biopsies in Early Phase Clinical Trials of Anticancer Agents for Pharmacodynamic Evaluation by DOWLATI, Afshin, HAAGA, John, REMICK, Scot C, SPIRO, Timothy P, GERSON, Stanton L, LIU, Lili, BERGER, Sosamma J, BERGER, Nathan A, WILLSON, James K. V

    Published in Clinical cancer research (01-10-2001)
    “…Purpose : In the setting of target-based anticancer drug development, it is critical to establish that the observed preclinical activity can be attributed to…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Venous thromboembolism in lymphoma: how effectively are we treating patients? by Muslimani, Alaa A, Spiro, Timothy P, Chaudhry, Asif A, Taylor, Harris C, Daw, Hamed A

    Published in American journal of clinical oncology (01-10-2009)
    “…Patients with solid tumors and venous thromboembolic episodes (VTE) have a high risk of recurrence and bleeding during oral anticoagulant treatment. However,…”
    Get full text
    Journal Article
  11. 11

    Venous thromboembolism in patients with monoclonal gammopathy of undetermined significance by Muslimani, Alaa A, Spiro, Timothy P, Chaudhry, Asif A, Taylor, Harris C, Jaiyesimi, Ishmael, Daw, Hamed A

    Published in Clinical advances in hematology & oncology (01-12-2009)
    “…Monoclonal gammopathy of undetermined significance (MGUS) is defined by the presence of a serum M-protein at a concentration of 3 g/dL or less, with less than…”
    Get full text
    Journal Article
  12. 12

    A Renal Mass in a Patient With Melanoma by Boughan, Kirsten M, Setrakian, Sebouh, Lee, Chi Hoon, Spiro, Timothy P, Daw, Hamed A

    Published in Clinical genitourinary cancer (01-10-2009)
    “…Abstract A 61-year-old man presented to the emergency room with significant weight loss. Laboratory analysis revealed elevations in blood urea nitrogen,…”
    Get full text
    Journal Article
  13. 13

    Secondary myelodysplastic syndrome after hydroxychloroquine therapy by Muslimani, Alaa A, Spiro, Timothy P, Chaudhry, Asif A, Daw, Hamed A

    Published in Annals of hematology (01-07-2007)
    “…Primary myelodysplastic syndromes (MDS) occur in the absence of exposure to ionizing radiation, chemotherapeutic agents or myelotoxic drugs, whereas secondary…”
    Get full text
    Journal Article
  14. 14

    Haematuria as an uncommon initial presenting symptom of metastatic squamous cell carcinoma (SCC) to kidney by Kawsar, Hameem I, Spiro, Timothy P, Daw, Hamed A

    Published in BMJ case reports (11-08-2011)
    “…A 47-year-old female presented with a 2-week history of painless haematuria. Urine dipstick showed moderate leucocytes. Blood and urine cultures were negative…”
    Get full text
    Journal Article
  15. 15

    BOOP as a rare complication of gemcitabine therapy by Kawsar, Hameem I, Spiro, Timothy P, Cocco, Amy, Daw, Hamed A

    Published in BMJ case reports (20-07-2011)
    “…Gemcitabine is commonly used in combination with carboplatin in patients with advanced non-small-cell lung cancer (NSCLC). Gemcitabine has good clinical…”
    Get full text
    Journal Article
  16. 16

    Complete Remission of Metastatic Carcinoma of the Prostate with Bicalutamide Withdrawal by Kundranda, Madappa N, Muslimani, Alaa, Daw, Hamed A, Spiro, Timothy P

    Published in Clinical genitourinary cancer (01-09-2007)
    “…Abstract An 83-year-old man was diagnosed with stage 4 prostate cancer with a Gleason score of 7 (3+4). His Initials prostate-specific antigen (PSA) level was…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Differential Degradation Rates of Inactivated Alkyltransferase in Blood Mononuclear Cells and Tumors of Patients after Treatment with O6-Benzylguanine by LIU, Lili, SPIRO, Timothy P, XIUSHENG QIN, MAJKA, Susan, HAAGA, John, SCHUPP, Jane, WILLSON, James K. V, GERSON, Stanton L

    Published in Clinical cancer research (01-08-2001)
    “…O 6 -Alkylguanine-DNA alkyltransferase (AGT) repairs O 6 -alkylating DNA adducts generated by alkylating therapeutic agents. Therefore, AGT activity may be an…”
    Get full text
    Journal Article
  19. 19

    Evaluation of Conventional Cytogenetics Versus Fluorescence in Situ Hybridization Analysis in the Prognostic Scoring of Patients with Myelodysplastic Syndromes by Maiti, Baidehi, Chahoud, Raymond, Spiro, Timothy P, Daw, Hamed A

    Published in Blood (20-11-2009)
    “…Abstract 1757 Poster Board I-783 The myelodysplastic syndromes (MDS) encompass a heterogeneous group of progressive bone marrow insufficiency disorders…”
    Get full text
    Journal Article
  20. 20

    Venous Thromboembolism in Lymphoma: How Effectively Are We Treating Patients? by Muslimani, Alaa A., Spiro, Timothy P., Chaudhry, Asif A., Daw, Hamed A.

    Published in Blood (16-11-2007)
    “…Introduction: Patients (pts) with solid tumors and venous thromboembolic episodes (VTE) have a high risk of complications (recurrent VTE/bleeding) during oral…”
    Get full text
    Journal Article